Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP Announces Hiring of MedTech Industry Veteran Ryan Rhodes as CEO of Company’s U.S. Subsidiary
Appointment brings highly experienced medical technology and commercialization leader to drive EDAP’s US expansion focus. Career accomplishments include 14 years at Intuitive Surgical, where he played a leading role in global clinical expansion of robotic surgery in multiple specialties including
View HTML
Toggle Summary EDAP Reports First Quarter 2021 Results and Provides Operational Update
Generated record first quarter revenue of EUR 10.3 million (USD 12.4 million), an increase of 35.4% year-over-year Increased gross margin year-over-year to 42.4%, contributing to a profitable quarter Raised gross proceeds of approximately $28 million through an underwritten offering of American
View HTML
Toggle Summary EDAP TMS SA to Announce First Quarter 2021 Financial Results on May 11, 2021
Company to host conference call and webcast on Wednesday , May 12 at 8:30 am EDT LYON, France, May 4 , 20 2 1 - EDAP TMS SA (Nasdaq: EDAP), a global leader in robotic energy-based therapies, today announced that it will release its financial results for the first quarter ended March 31, 2021 after
View HTML
Toggle Summary EDAP Announces Pricing of Follow-On Offering
LYON, France, April 23, 2021 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced that the price of its offering of American Depositary Shares (“ADS”) has been set at $6.75 per ADS and that the number of offered ADSs is 4,150,000 for an
View HTML
Toggle Summary EDAP Announces Launch of Follow-On Offering
LYON, France, April 22, 2021 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today the launch of a follow-on public offering of its American Depositary Shares, or ADSs, each representing one ordinary share of the Company.
View HTML
Toggle Summary EDAP Reports Fourth Quarter 2020 Results and Provides Operational Update
Generated record fourth quarter revenue of EUR 15.4 million ( USD 18.3 million ), an increase of 28% year-over-year; HIFU revenue up 51% year-over-year Generated €41.7 million revenue and profitable operating result for the full year 2020. Completed sales to renowned healthcare institutions, such
View HTML
Toggle Summary EDAP TMS SA to Announce Fourth Quarter and Full Year 2020 Financial Results on March 30, 2021
Company to host conference call and webcast on Wednesday, March 31 at 8:30 am EDT LYON, France , March 23, 2020 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and year ended
View HTML
Toggle Summary EDAP Selects Leading Reimbursement Consultancies MTP and Argenta Advisors to Expand Market Access and Coverage of HIFU in the US
  Initiatives focused on making HIFU procedures broadly accessible to both Medicare and commercially insured patients  LYON, France , March 3, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, announces today that the company has selected
View HTML
Toggle Summary EDAP Announces Record Preliminary Unaudited Fourth Quarter 2020 Revenue of EUR 15.3 Million [$18.3 million], an Increase of 28% Year-Over-Year
  Record HIFU revenue growth of 50% in the fourth quarter 2020 driven by the sale of eight HIFU devices sold during the quarter Achieved sequential quarterly revenue growth throughout 2020 notwithstanding challenges posed by the ongoing COVID-19 pandemic Company to announce fourth quarter and full
View HTML
Toggle Summary EDAP to Participate in B. Riley Securities Virtual Oncology Investor Conference
  LYON, France , January 19, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, today announced that Marc Oczachowski , President and CEO, will participate in a fireside chat at the B. Riley Securities Virtual Oncology Investor Conference on
View HTML